• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prevention of vestibular deafferentation-induced spontaneous nystagmus with pretreatment of Ca2+ channel/N-methyl-D-aspartic acid receptor antagonists in guinea pigs.

作者信息

Aoki M, Ito Y, Miyata H

机构信息

Department of Otorhinolaryngology, Gifu University School of Medicine, Japan.

出版信息

Acta Otolaryngol. 1998 Jul;118(4):554-6. doi: 10.1080/00016489850154711.

DOI:10.1080/00016489850154711
PMID:9726682
Abstract

Involvement of Ca2+ channel and N-methyl-D-aspartic acid (NMDA) receptors with induction of the spontaneous nystagmus (SN) after unilateral labyrinthectomy (UL) was evaluated by examining the effect of verapamil and MK-801 in guinea pigs. An injection of verapamil or MK-801 before the intratympanic application of arsanilate significantly (p < 0.05) suppressed the frequency of the SN towards the arsanilate-applied side. The frequency of the SN towards the intact side in these drug-treated animals was much lower than in the control animals until 36 h after the application of arsanilate. In addition, 60 days subsequent to induction of the UL, application of the drug before we injected the arsanilate into the opposite middle ear suppressed the SN towards the second arsanilate-injected side, but not towards the first injection side. We suggest that Ca2+ channel and NMDA receptor may be involved in the induction of the SN, and that the pretreatment of their antagonists could be applied in preventing the vestibular deafferentation-induced SN.

摘要

相似文献

1
Prevention of vestibular deafferentation-induced spontaneous nystagmus with pretreatment of Ca2+ channel/N-methyl-D-aspartic acid receptor antagonists in guinea pigs.
Acta Otolaryngol. 1998 Jul;118(4):554-6. doi: 10.1080/00016489850154711.
2
Evidence for the involvement of NMDA receptors in vestibular compensation.N-甲基-D-天冬氨酸受体参与前庭代偿的证据。
J Vestib Res. 1996 Jul-Aug;6(4):315-7.
3
Vestibular nucleus N-methyl-D-aspartate receptors contribute to spontaneous nystagmus generation following unilateral labyrinthectomy in guinea pigs.前庭核N-甲基-D-天冬氨酸受体在豚鼠单侧迷路切除术后对自发性眼球震颤的产生起作用。
Neurosci Lett. 2000 Apr 7;283(2):117-20. doi: 10.1016/s0304-3940(00)00933-2.
4
Comparison of the effects of pretreatment with competitive or noncompetitive NMDA antagonists on vestibular compensation.
Pharmacol Biochem Behav. 1993 Dec;46(4):807-11. doi: 10.1016/0091-3057(93)90205-8.
5
Pretreatment with MK-801 reduces spontaneous nystagmus following unilateral labyrinthectomy.用MK-801进行预处理可减少单侧迷路切除术后的自发性眼球震颤。
Eur J Pharmacol. 1992 Sep 22;220(2-3):123-9. doi: 10.1016/0014-2999(92)90739-q.
6
Roles of glutamate receptor subtypes in the development of vestibular compensation after unilateral labyrinthectomy in the guinea pig.
Neurosci Lett. 2000 Dec 22;296(2-3):158-62. doi: 10.1016/s0304-3940(00)01633-5.
7
The effects of N-methyl-D-aspartate antagonists on the development of vestibular compensation in the guinea pig.
Eur J Pharmacol. 1989 Dec 19;174(2-3):273-8. doi: 10.1016/0014-2999(89)90320-8.
8
Pre-treatment with a Ca2+ channel antagonist facilitates vestibular compensation.用钙离子通道拮抗剂进行预处理有助于前庭代偿。
Neuroreport. 1992 Feb;3(2):143-5. doi: 10.1097/00001756-199202000-00005.
9
Role of vestibulocerebellar N-methyl-D-aspartate receptors for behavioral recovery following unilateral labyrinthectomy in rats.
Neurosci Lett. 1997 Feb 7;222(3):171-4. doi: 10.1016/s0304-3940(97)13371-7.
10
Recovery of vestibulogastrointestinal symptoms during vestibular compensation after unilateral labyrinthectomy in rats.大鼠单侧迷路切除术后前庭代偿期间前庭-胃肠症状的恢复。
Otol Neurotol. 2010 Feb;31(2):241-9. doi: 10.1097/MAO.0b013e3181cabd5d.

引用本文的文献

1
Pharmacological treatment of vertigo.眩晕的药物治疗。
CNS Drugs. 2003;17(2):85-100. doi: 10.2165/00023210-200317020-00002.